106 related articles for article (PubMed ID: 2508464)
1. Treatment of recurrent cervical cancer with cis-platinum and mitomycin C: a phase II study.
Malviya VK; Deppe G; Schoenmaker M
Am J Clin Oncol; 1989 Oct; 12(5):438-41. PubMed ID: 2508464
[TBL] [Abstract][Full Text] [Related]
2. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR
Gynecol Oncol; 1990 Apr; 37(1):21-3. PubMed ID: 1691126
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer.
Serkies K; Jassem J; Dziadziuszko R
Int J Gynecol Cancer; 2006; 16(3):1152-6. PubMed ID: 16803499
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.
Wagenaar HC; Pecorelli S; Mangioni C; van der Burg ME; Rotmensz N; Anastasopoulou A; Zola P; Veenhof CH; Lacave AJ; Neijt JP; van Oosterom AT; Einhorn N; Vermorken JB
Eur J Cancer; 2001 Sep; 37(13):1624-8. PubMed ID: 11527687
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
[TBL] [Abstract][Full Text] [Related]
7. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.
Delaloye JF; Leyvraz S; Outcha Adjahoto E; Bauer J; De Grandi P
Am J Clin Oncol; 1996 Apr; 19(2):204-6. PubMed ID: 8610651
[TBL] [Abstract][Full Text] [Related]
9. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for advanced and/or recurrent cervical cancer.
Lahousen M; Pickel H; Tamussino K
Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced cervical cancer by a combination of peplomycin, vincristine, mitomycin-C, and cisplatin.
Sugimori H; Iwasaka T; Fukuda K; Hayashi Y; Hachisuga T
Gynecol Oncol; 1989 Aug; 34(2):180-2. PubMed ID: 2473949
[TBL] [Abstract][Full Text] [Related]
12. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix.
Choi CH; Kim TJ; Lee SJ; Lee JW; Kim BG; Lee JH; Bae DS
Int J Gynecol Cancer; 2006; 16(3):1157-64. PubMed ID: 16803500
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.
John M; Flam M; Sikic B; Rotman M; Cooper J; Malec M; Hannigan J; Phillips T
Gynecol Oncol; 1990 Apr; 37(1):1-5. PubMed ID: 2108909
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
[TBL] [Abstract][Full Text] [Related]
15. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
[TBL] [Abstract][Full Text] [Related]
16. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: a pilot study.
Malviya VK; Deppe G; Kim Y; Gove N
Am J Clin Oncol; 1989 Oct; 12(5):434-7. PubMed ID: 2508463
[TBL] [Abstract][Full Text] [Related]
17. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR; Myers M
Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of 5-fluorouracil/cisplatinum in recurrent cervical cancer.
Kaern J; Tropé C; Abeler V; Iversen T; Kjørstad K
Acta Oncol; 1990; 29(1):25-8. PubMed ID: 2310600
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Yasui Y; Suzumori K; Asai H; Yagami Y
Gan No Rinsho; 1985 Sep; 31(11):1415-21. PubMed ID: 2415720
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effect of combination chemotherapy with peplomycin and mitomycin C (PM therapy) in recurrent uterine cervical cancer].
Yokoyama T; Hiura M; Kaneko H; Yorishima M; Tanaka M; Chiba T
Gan To Kagaku Ryoho; 1988 Jan; 15(1):73-8. PubMed ID: 2447837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
